The Influence of Honey-flavored Yogurt on Low-grade Inflammation and Gut Health in Middle to Older Aged Women.
Part of paid clinical trials in Davis, California.
- Sponsor
- University of California, Davis
- Study ID
- NCT04248127
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 45 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- Honey sweetened yogurt — OTHER2 tbsp. of daily honey intake in 1.2 cups of yogurt per day, split into two equal portions
- Sugar sweetened yogurt — OTHERsugar added, in an isocaloric fashion to the honey, to 1.2 cups of yogurt per day, split into two equal portions
Study Details
A randomized, double-blind, crossover dietary intervention trial will test the effects of 4 weeks of daily honey-flavored yogurt intake on markers of inflammation (Th17 cytokines) and oxidative stress (NOX2, UA, RSNO) and associative changes with microbial derived metabolites (SCFAs, BAs, ellagitannins), metabolism and the fecal microbiome. The above suite of selected markers will capture diet-induced systemic changes in inflammation and oxidative stress, while assessing associated microbial changes.
Key Dates
- Start date
- Nov 1, 2021
- Status verified
- Feb 2026
- Primary completion
- Jul 25, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- PREVENTION
Arms
- Experimental: Honey sweetened yogurt1 tbsp. of honey in 0.6 cup (150g) of plain yogurt. The participants will be asked to consume 2 morning servings of the yogurt for a total of 2 tbsp. of the assigned honey per day.
- Placebo Comparator: Sugar sweetened yogurtSugar will be added to 0.6 cup (150g) of plain yogurt in an isocaloric amount compared to the honey. The participants will be asked to consume 2 morning servings of the yogurt per day.
Primary Outcome Measure
Concentration of CD4+ T Helper (TH)17 cytokines [ Time Frame: 4 weeks ]
Central Contacts
- Robert R Holt, PhD530-752-4950
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, Davis; Department of Nutrition | Davis | California | 95616 |
Find similar trials in Davis, CA
By condition
By specialty
Related Studies
- Avoid and Resist Strategies for Weight ManagementRecruiting · Cedars-Sinai Medical Center · Los Angeles, California
- Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/ObesityPHASE2 · Recruiting · Stanford University · Palo Alto, California
- A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightPHASE2 · Recruiting · Eli Lilly and Company · Chandler, Arizona
- A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)PHASE3 · Recruiting · Eli Lilly and Company · Ventura, California